Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Novo Nordisk A/S Class B (NOVCb)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
Novo Nordisk B historical data, for real-time data please try another search
58.66 +0.05    +0.09%
05/10 - Closed. Currency in EUR ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 58.66 - 58.66
Type:  Equity
Market:  Germany
ISIN:  DK0060534915 
S/N:  A1XA8R
Novo Nordisk B 58.66 +0.05 +0.09%

NOVCb Balance Sheet

 
Assess the latest Novo Nordisk A/S Class B balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Even more advanced NOVOb Annual Report data, financial summaries and charts are available for Novo Nordisk A/S Class B investors with their own InvestingPro account.
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Collapse All
Period Ending: 2014
30/06
 2014
31/03
 2013
31/12
 2013
30/09
Total Current Assets 34215 34506 42058 369.39
Cash and Short Term Investments 6523 5168 14469 198.72
Cash 5001 2640 10728 9428
Cash & Equivalents - - - 197.03
Short Term Investments 1522 2528 3741 1.68
Total Receivables, Net 16777 18097 16516 67.43
Accounts Receivables - Trade, Net 11515 10481 10907 37.45
Total Inventory 10699 10299 9552 43.38
Prepaid Expenses - - - 8.44
Other Current Assets, Total 216 942 1521 51.42
Total Assets 63681 63241 70337 3454.18
Property/Plant/Equipment, Total - Net 22168 21905 21882 3034.5
Property/Plant/Equipment, Total - Gross - - - 3554.39
Accumulated Depreciation, Total - - - -555.56
Goodwill, Net - - - -
Intangibles, Net 1709 1684 1615 1682
Long Term Investments 771 749 551 41.34
Note Receivable - Long Term - - - 6.19
Other Long Term Assets, Total 4818 4397 4231 2.76
Other Assets, Total - - - -
Total Current Liabilities 23748 26397 24225 248.07
Accounts Payable 2988 3490 4092 20.4
Payable/Accrued - - - -
Accrued Expenses - - - 53.08
Notes Payable/Short Term Debt 406 804 215 -
Current Port. of LT Debt/Capital Leases - - - 127.62
Other Current liabilities, Total 20354 22103 19918 46.98
Total Liabilities 27020 29658 27768 1525.44
Total Long Term Debt - - - 1262.46
Long Term Debt - - - 1156.48
Capital Lease Obligations - - - 105.97
Deferred Income Tax 442 517 672 448
Minority Interest - - - -
Other Liabilities, Total 2830 2744 2871 14.91
Total Equity 36661 33583 42569 1928.74
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 530 550 550 10.06
Additional Paid-In Capital - - - 0.28
Retained Earnings (Accumulated Deficit) 36105 32365 41137 1922.7
Treasury Stock - Common -6 -23 -21 -4.31
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 32 691 903 774
Total Liabilities & Shareholders' Equity 63681 63241 70337 3454.18
Total Common Shares Outstanding 2615.26 2631.26 2217.2 200.44
Total Preferred Shares Outstanding - - - -
* In Millions of (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

NOVOb Price Commentary

Write your thoughts about Novo Nordisk A/S
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Roger Amrein
Roger Amrein Dec 19, 2022 14:35
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
What do you mean?
Reply
0 1
Report
Escobar Sy
Escobar Sy Dec 17, 2022 4:42
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
how can we do it
Reply
1 0
Report
Nov 02, 2022 22:32
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Tjek dette
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email